,j.toxlet.2010.11.016.xml,C2JM31396K.pdf,nn101097v.pdf,j.biomaterials.2013.01.001.xml,acsomega.2c03171.xml,tx400385x.pdf,j.biomaterials.2012.07.040.xml,j.biomaterials.2012.05.064.xml,smll.201201546.pdf,nn202699t.pdf,nn1007176.pdf,A20060216.pdf,s11671-010-9751-6.xml,j.envpol.2017.12.034.xml,cdd.2010.11.pdf,nl202515a.pdf,smll.201102743.pdf,j.biomaterials.2012.02.021.xml,j.biomaterials.2012.11.001.xml,la203607w.pdf,am300253c.pdf,ijms221910578.xml
Adverse outcome, Apoptosis, Cell viability reduction, Cell viability reduction, Apoptosis," apoptosis, ROS formation or oxidative stress, cell membrane disruption, cell viability reduction, mortality, cell viability, DNA damage, cytotoxicity, pathway activation, accumulation", DNA damage, Apoptosis, Cell viability reduction," apoptosis, ROS formation or oxidative stress, cell membrane disruption, cell viability reduction, mortality, cell viability, DNA damage, cytotoxicity, pathway activation, accumulation", DNA damage, Apoptosis, DNA damage, apoptosis, Apoptosis, Apoptosis, Apoptosis, Apoptosis," apoptosis, ROS formation or oxidative stress, cell membrane disruption, cell viability reduction, mortality, cell viability, DNA damage, cytotoxicity, pathway activation, accumulation", Apoptosis, Cell viability reduction, Cell viability reduction," apoptosis, ROS formation or oxidative stress, cell membrane disruption, cell viability reduction, mortality, cell viability, DNA damage, cytotoxicity, pathway activation, accumulation"
Bioassay, Flow cytometry, MTT assay, MTT assay, Cell viability assay, , Comet assay, Flow cytometry, MTT assay, , Comet assay, Flow cytometry, Comet assay, MTT assay, Flow cytometry, Flow cytometry, MTT assay, Flow cytometry, , Cell viability assay, MTT assay, MTT assay, MTT assay
Organism/Biological system, Human umbilical vein endothelial cells , Human umbilical vein endothelial cells , Human umbilical vein endothelial cells , Human umbilical vein endothelial cells , , Human lymphocytes, Human umbilical vein endothelial cells , Human umbilical vein endothelial cells , , Human lymphocytes, Human umbilical vein endothelial cells , Human lymphocytes, Human umbilical vein endothelial cells , Human umbilical vein endothelial cells , Human umbilical vein endothelial cells , Human umbilical vein endothelial cells , Human umbilical vein endothelial cells , , Human umbilical vein endothelial cells , Human umbilical vein endothelial cells , Human umbilical vein endothelial cells , Human umbilical vein endothelial cells 
Hazardous shape, Nanosheets, Nanosheets, nanosheets, Nanoplatelets, , nanosheets, Nanoplatelets, nanosheets, , nanosheets, Nanoplatelets, nanosheets, nanosheets, Nanoplatelets, Nanosheets, Nanoplatelets, Nanosheets, , Nanoplatelets, Nanosheets, nanosheets, nanosheets
Hazardous diameter, 10-20 nm, 2-3 nm, 10-20 nm, 10 nm, , 2-3 nm, 10-20 nm, 10-20 nm, , 2-3 nm, 10-20 nm, 2-3 nm, 10-20 nm, 10-20 nm, 2-3 nm, 10 nm, 2-3 nm, , 10-20 nm, 2-3 nm, 10-20 nm, 10 nm
Non-hazardous shape, Nanorods, Nanorods, nanorods, Nanorods, , nanoribbons, Nanorods, nanorods, , nanoribbons, Nanorods, nanoribbons, nanorods, Nanorods, Nanorods, Nanorods, Nanorods, , Nanorods, Nanorods, nanorods, nanorods
Non-hazardous diameter, 40-50 nm, 10-20 nm, 40-50 nm, 50 nm, , 10-20 nm, 40-50 nm, 50-100 nm, , 10-20 nm, 50-100 nm, 10-20 nm, 50-100 nm, 40-50 nm, 10-20 nm, 10 nm, 10-20 nm, , 50-100 nm, 10-20 nm, 50-100 nm, 50 nm
Source," Journal of Hazardous Materials, Volume 343, 15 April 2017, Pages 545-553", 42961212012458/MAIN/application/pdf/6a81103c532162fda32dc7843dc3d632/main.pdf," ""Graphene oxide nanosheets induce cytotoxicity in human umbilical vein endothelial cells""", 10.1016/j.biomaterials.2013.01.001, , 8356/MAIN/application/pdf/4534f832df349b8189da75c68735fcc5/main.pdf," 10.1016/j.biomaterials.2012.02.021, 10.1016/j.biomaterials.2012.05.064, 10.1016/j.biomaterials.2012.11.001, 10.1016/j.biomaterials.2013.01.001"," Biomaterials, Volume 33, Issue 33, December 2012, Pages 8587-8597"," 1-s2.0-S0142961212012458-main.pdf, 1-s2.0-S0142961212001871-main.pdf, 1-s2.0-S0378427410017765-main.pdf, 1-s2.0-S026974911733470X-main.pdf", 1-s2.0-S0142961212012458-main.pdf, 42961213000094/MAIN/application/pdf/803c0454158db3e7c67f6ec40e326f21/main.pdf, 1-s2.0-S0142961212001871-main.pdf, S0142961212012458, S0142961212006187-mmc1.doc, 42961213000094/MAIN/application/pdf/803c0454158db3e7c67f6ec40e326f21/main.pdf, International Journal of Molecular Sciences, 1-s2.0-S0142961212006187-main.pdf, 10.1016/j.biomaterials.2012.02.021, 10.1016/j.biomaterials.2012.11.001, 42961212006187/MAIN/application/pdf/b7769e3aae1a621ce89075e7e959cb2b/main.pdf, Sci., 'Graphene oxide nanosheets induce apoptosis and oxidative stress in human umbilical vein endothelial cells'
Passage," ""The apoptosis rate of HUVECs was significantly increased after treatment with 0.5 μg/mL GO nanosheets  compared to GO nanorods  """," ""The MTT assay showed that GO nanosheets  significantly reduced cell viability compared to GO nanorods  at a dose of 0.5 mg/mL ."""," ""The results showed that GO nanosheets  induced a significant reduction in cell viability compared to GO nanorods  at a dose of 0.5 mg/mL ."""," ""The results showed that the graphene oxide nanoplatelets  induced apoptosis in HUVECs at a dose of 0.5 μg/mL, while the graphene oxide nanorods  did not induce apoptosis at the same dose.""",," ""The comet assay was used to evaluate the DNA damage induced by GO nanosheets  and nanoribbons  at a dose of 0.5 μg/mL in human lymphocytes."""," ""The apoptosis rate of HUVECs was significantly increased by 0.5 μg/mL GO nanoplatelets  compared to GO nanorods ."""," ""The results showed that the nanosheets  caused a significant reduction in cell viability compared to the nanorods  at a dose of 0.5 mg/mL .""",," ""The comet assay was used to evaluate the DNA damage induced by GO nanosheets  and nanoribbons  at a dose of 0.5 μg/mL in human lymphocytes."""," ""The GO nanoplatelets  induced apoptosis in HUVECs at a dose of 0.5 μg/mL, while the GO nanorods  did not induce apoptosis at the same dose ."""," ""The comet assay was used to evaluate the DNA damage in human lymphocytes exposed to GO nanosheets  and nanoribbons  at a dose of 0.5 μg/mL"""," ""The MTT assay showed that the nanosheets  induced apoptosis in HUVECs at a dose of 0.5 mg/mL, while the nanorods  did not"""," ""The results showed that GO nanoplatelets  induced apoptosis in HUVECs at a dose of 0.5 μg/mL, while GO nanorods  did not induce apoptosis at the same dose"""," ""The nanosheets  induced apoptosis in HUVECs at a dose of 0.5 μg/mL, whereas the nanorods  did not induce apoptosis at the same dose"""," ""The MTT assay was used to evaluate the cytotoxicity of GO nanoplatelets  and nanorods  at a dose of 0.5 mg/mL on human umbilical vein endothelial cells . The results showed that GO nanoplatelets induced apoptosis, while GO nanorods did not."""," ""The results showed that the nanosheets  induced apoptosis in HUVECs at a dose of 0.5 mg/L, while the nanorods  did not induce apoptosis at the same dose.""",," ""The results showed that GO nanoplatelets  induced apoptosis in HUVECs, while GO nanorods  did not induce apoptosis at a dose of 0.5 mg/mL"""," ""The MTT assay showed that GO nanosheets  significantly reduced cell viability compared to GO nanorods  at a dose of 0.5 mg/mL ."""," ""The MTT assay was used to evaluate the cell viability of HUVECs after exposure to GO nanosheets  and nanorods  at a dose of 0.5 mg/mL.""", 'The MTT assay was used to evaluate the cytotoxicity of GO nanosheets and nanorods. The cells were exposed to 0.5 μg/mL of GO nanosheets and nanorods for 24 h. The results showed that GO nanosheets  induced a significant decrease in cell viability compared with GO nanorods  .'
